Dynamin 2 interacts with α-actinin 4 to drive tumor cell invasion

Area of Science:

• Cell Biology
• Cancer Research
• Biochemistry

Background:

• The large GTPase Dynamin 2 (Dyn2) is implicated in increasing pancreatic cancer cell invasiveness.
• The precise mechanisms by which Dyn2 influences the actin cytoskeleton to promote cell migration remain largely unknown.

Purpose of the Study:

• To investigate the interaction between Dynamin 2 (Dyn2) and alpha-actinin (α-actinin) in pancreatic ductal adenocarcinoma (PDAC) cells.
• To elucidate the role of the Dyn2-α-actinin interaction in regulating actin cytoskeleton dynamics, cell migration, and extracellular matrix remodeling.

Main Methods:

• Investigated the direct interaction between Dyn2 and α-actinin 4 using biochemical assays.
• Examined the localization of Dyn2 and α-actinin 4 at invasive structures in PDAC cells.
• Disrupted the Dyn2-α-actinin 4 interaction to assess its impact on cell migration and invadopodia stability.
• Analyzed human PDAC tumor tissue for Dyn2 and α-actinin 4 expression levels.

Main Results:

• A direct interaction between Dyn2 and α-actinin 4, mediated by their C-terminal tails, was identified at the plasma membrane.
• Only the Dyn2-α-actinin 4 interaction, not Dyn2-α-actinin 1, is essential for promoting tumor cell invasion.
• Disruption of the Dyn2-α-actinin 4 interaction significantly impaired PDAC cell migration and invasion by destabilizing invadopodia.
• Elevated expression of α-actinin 4 or Dyn2 in human PDAC tissues correlated with poorer patient survival.

Conclusions:

• Dyn2 regulates cytoskeletal dynamics during tumor cell invasion through its interaction with the actin-binding protein α-actinin 4.
• The Dyn2-α-actinin 4 interaction is a critical determinant of PDAC cell migration, invasion, and extracellular matrix remodeling.
• Dyn2 and α-actinin 4 represent potential prognostic biomarkers and therapeutic targets in pancreatic cancer.